Morphological fibrocystic changes have been associated with an increased risk of development of breast cancer (Jensen et al., 1976; Bartow et al., 1982; Love et al., 1982; Hutter et al., 1986) . Ever-parous vs nulliparous status, early age at first full-term pregnancy and high total parity are among factors that epidemiological studies have identified as exerting protective effects on breast cancer risk (MacMahon et al., 1970; Kelsey, 1979; Bain et al., 1981; Lubin et al., 1982; Helmrich et al., 1983) . The relationship between these reproductive factors and fibrocystic disease is unclear.
This study was undertaken to examine the relationship between parity factors and prevalence of morphologic fibrocystic changes. The case series was a subset from a larger autopsy series in which the prevalence of morphologic subsets of fibrocystic change was examined in three ethnic/ racial groups at differing risk for breast cancer (Bartow et al., 1987) . The three groups were all women from the New Mexico and eastern Arizona area on whom autopsies were performed by the New Mexico Medical Investigator's Office. The deaths were usually sudden, unexpected and often traumatic rather than a consequence of disease. Annual age adjusted breast cancer incidence rates for women in this geographic area are: Anglos (non-Hispanic whites), 81.4/ 100,000; Hispanics, 54.1/100,000; and American Indians, 28.5/10,000 (Surveillance, Epidemiology, and End Results (SEER), 1984) .
In the original series, prevalence of marked fibrocystic changes paralleled the breast cancer risk pattern (Bartow et al., 1987) . It was of interest to see if, within each ethnic/racial group, the parity factors would show an effect on the prevalence of morphologic fibrocystic changes independent of ethnic/racial factors. Histologic evaluation was of specific morphologic subsets of 'fibrocystic change'. These subsets were evaluated individually rather than in a constellation because of increasing evidence that breast cancer risk is associated with some, but not all, of the subsets. Cystic change, apocrine metaplasia, intraductal epithelial hyperplasia, sclerosing adenosis, and lobular microcalcification were included in the histologic evaluation. A scoring scheme was designed to give weighted summary scores combining extent and degree of these changes (Table II) . Cystic change, apocrine metaplasia and were also recorded. After determining the raw scores, these scores were divided into two categories corresponding to minor and marked degree of the change. The raw score ranges encompassed by these categories varied with each histologic parameter. The category of 'marked change' was based on sufficient change being present to warrant being specified by the pathologist in a diagnostic biopsy. Only 'marked change' was used for analysis by parity parameters.
Materials and methods
Information regarding parous or nulliparous status was available on all 336 women. Age at first full-term pregnancy could not be ascertained, and, for this study, age at first birth was taken as a surrogate. For the 231 ever-parous women, age at first birth was available on 158 (68%) women, and total parity on 177 (77%). Initially, odds ratios for the various parity parameters were calculated separately for each ethnic/racial and age ( <34, 35-54, > (Bartow et al., 1987) . Fibrocystic changes were infrequent in the < 34 years of age group, peaked in the 35-54 years of age group, and decreased in the > 55 years group. This age-related pattern was seen in all three ethnic/racial groups.
Among the subsets of morphologic fibrocystic disease, cystic change was the most common, followed by apocrine metaplasia and intraductal epithelial hyperplasia. Only these changes were included in the analysis by parity parameters. Sclerosing adenosis and lobular microcalcification were too uncommon for analysis. Three cases of atypical ductal and two of atypical lobular hyperplasia were identified. All were in women over 40 years of age. Comparison of the 336 women included in this study with the 154 who did not have parity status information did not show any significant differences in the prevalence of the various subsets of fibrocystic disease considered in this study.
Summary odds ratios (ORs), adjusted for age and ethnicity, for the various histologic parameters by parity status (Table III) were calculated using the exact stratified analysis of 2 x k tables method in the EGRET statistical package (Epidemiological Graphics, Estimation, and Testing Package). Tests combining the ever/never-parous results with the reduced data on parity and age at first birth used the Mantel-Haenszel method. Tables with any zero marginals were omitted from the summary results below.
Exact stratified analyses of 2 x k tables were also used for calculating the odds ratios for the various histologic parameters by ethnicity (Table IV) adjusted for age and parity status.
Power and sample size calculations were carried out using the formula for sample size calculations when comparing two binomial distributions (Casagrande et al., 1978) . Program POWER in the EPILOG PLUS statistical package was used for actual calculations (EPILOG PLUS, 1989) .
Results
Marked cystic ductal dilatation was less common in parous than in nulliparous women (OR = 0.81, Table III ). Risk of cystic change decreased with increasing parity and was lowest in women who had a first birth before age 25. Increasing parity was associated with a lower risk even after adjusting for age at first birth (OR = 0.66), and the effect of earlier age at first birth also remained after adjusting for total parity (ORs of 1.00, 0.83, 1.81 for <20, 21-24, 25 +, respectively). None of these results was, however, statistically significant, even when the ever/never-parous category result was combined, statistically, with the results for age at first birth and total parity: Mantel-Haenszel test for age at first birth plus ever/never parous -Chi-square = 2.20 on 1 degree of freedom, P = 0.14; Mantel-Haenszel test for total parity plus ever/ never parous -Chi-square = 0.95 on 1 degree of freedom,
Marked apocrine metaplasia was less common in parous than in nulliparous women (OR = 0.71, Table III), but risk increased with increasing parity and earlier age at first birth so that it was not reasonable to combine the ever/neverparous result with the total parity or age at first birth result. The frequency of apocrine metaplasia was low and none of the results was statistically significant.
Marked intraductal epithelial hyperplasia was less common in parous than in nulliparous women (OR = 0.72, Table III) , and risk decreased with increasing parity although not with earlier age at first birth. The frequency of intraductal epithelial hyperplasia was also low and none of these results was statistically significant, including the result combining, statistically, the ever/never-parous result with the result for total parity (Mantel-Haenszel test -Chi-square = 0.36 on 1 degree of freedom, P = 0.55).
Although none of the results reached statistical significance, the prevalence of marked changes for all three histologic parameters considered was consistently lower in the ever-parous than in the nulliparous women. Sample size calculations for a cohort design, showed that for cystic change, if the prevalence of marked cystic change in nulliparous is assumed to be .30, to detect OR = .75, at significance level = .05 with power = .80, approximately 590 nulliparous and 1180 ever-parous women would be required i.e., five times the current sample size. For apocrine metaplasia and intraductal epithelial hyperplasia, if the prevalence of marked changes in the nulliparous is assumed to be .15, to detect OR = .75, at a = .05 with power = .80, approximately 1010 nulliparous and 2020 ever-parous women would be required i.e., ten times the current sample size.
In a previous paper (Bartow et al., 1987 ), significant differences in the prevalence of fibrocystic change were observed in the three ethnic/racial groups in this series. To assess whether some of these differences could be explained by differences in distribution of the parity factors in the three ethnic/racial groups, the histologic parameters were adjusted for parity status (Table IV) . Marked cystic change paralled the breast cancer pattern for the three ethnic/racial groups. When adjusted for age and never/ever-parous status, all three groups differ from each other, with cystic change being less common in Hispanics than Anglos (OR =.38) and least common in American Indians (OR= .25).
The pattern for marked apocrine metaplasia and intraductal epithelial hyperplasia was different. The prevalence of these histologic parameters did not differ between Anglos and Hispanics but was significantly lower for American Indians. This pattern persisted after adjustment for age and never/ever-parous status (Table IV) .
Discussion
Ever-parous vs nulliparous status, early age at first full-term pregnancy and multiparity have been identified by epidemiological studies as protective against the development of breast carcinoma (MacMahon et al., 1970; Kelsey, 1979; Bain et al., 1981; Lubin et al., 1982; Helmrich et al., 1983) . Although the effect of term pregnancy has been extensively evaluated, the mechanism of this protection has not been defined. One hypothesis is that full-term pregnancy changes the breast epithelium in a way that renders it less susceptible to carcinogenesis (Cairns, 1975) .
Cairns postulated that the stem cells of breast epithelium increase in number at puberty and then fluctuate with each ovarian cycle. He hypothesised that each full-term pregnancy induces more of these cells to fully differentiate with a resultant decrease in vulnerability to cancerous induction.
In humans, both carcinoma and most benign epithelial proliferative lesions, recently identified as having the highest association with carcinoma Hutter et al., 1986; Page et al., 1985) originate in the terminal ducts of the lobular unit of the breast (Jensen et al., 1976) . It is the epithelial cells in these structures that show mitotic activity and apoptosis resulting in architectural fluctuations during the menstrual cycle, as well as in pregnancy (Longacre & Bartow, 1986) . If full-term pregnancy induces these cells to fully differentiate, it would be reasonable to assume that occurrence of pregnancy may protect against the development of the putative precursor lesions of fibrocystic change as well as against the development of cancer.
Berkowitz (Berkowitz et al., 1985) and Hsieh (Hsieh et al., 1984) , in their studies of risk factors for fibrocystic breast disease, did not find an association between age at first birth and the occurrence of fibrocystic change. However, Hsieh found that women with high total parity were at decreased risk for fibrocystic breast disease. Berkowitz observed a similar effect of high total parity, but only for premenopausal women. No decrease in risk was observed for the ever-parous as compared to nulliparous women in the Berkowitz study.
This comparison was not possible in the Hsieh series because of the study design.
In this study, the odds ratios for significant fibrocystic change based on ever-parous status were consistently lower than 1. This is strongly suggestive of a protective effect of parity against cystic change, apocrine metaplasia and intraductal epithelial hyperplasia. Increasing parity (3 + vs 1-2) was also associated with a slightly lower prevalence of cystic change and intraductal epithelial hyperplasia, but even after combining these results with those ever/never-parous status, the results did not approach statistical significance. This is the first attempt to examine the interaction of parity parameters with fibrocystic change in a cohort of unselected, consecutive autopsies. When designing this study, no estimate was available. of the magnitude of the effects which might be observed. Differences of the order indicated by these results are, unfortunately, not measurable as statistically significant with the number of cases in this series. Any future study will need to include at least 1,000 nulliparous and 2,000 parous women to detect such differences in prevalence of fibrocystic change induced by parity status as statistically significant.
A potential limitation of this study was the lack of medical information for all 519 cases, resulting in possible bias due to nonrandom availability of information. However, comparisons of the mean scores for all the fibrocystic changes between the subset of 336 women and the total series did not show any systematic differences. Although inaccuracies resulting from surrogate data were to some degree anticipated in designing the questionnaire, undoubtedly some were introduced from this source: this will have reduced the power of the study through biasing the results towards 'no effect'.
The original study from which these cases were derived was designed to see if the known ethnic/racial differences in breast cancer incidence could be partially explained by differences in distribution of fibrocystic breast changes in these ethnic/racial groups. As can be seen in Table IV , differences in prevalence of fibrocystic breast changes, especially cystic change, generally parallels the breast cancer incidence pattern for the three ethnic/racial groups. The distribution of parity factors also differ in our samples from these three groups, so that failure to adjust for parity status could account for some of the differences in prevalence of the histologic parameters. Adjustment for parity status did not, however, alter the estimates of odds ratios for fibrocystic change in the three ethnic/racial groups. Additionally, differences in the distribution of relative body weight as measured by Quetelet's index (weight in kilograms/height2 in meters) also failed to account for the observed ethnic/racial differences in odds ratios of fibrocystic change (unpublished data). Thus, as with breast cancer, the ethnic/racial differences of fibrocystic change prevalence remain unexplained. This does not preclude the possibility that these differences are determined by other less easily evaluated cultural factors (e.g. diet) rather than genetic factors.
